Vanguard S&P 500 Growth Index Fund ETF (VOOG) Stock Price Today
Aura AI Summary
Key Stats
- -Market Cap
- -Volume
- Broad Market / FactorSector
- $85.6952W High
- $65.3252W Low
- -Typical Hold Time
- -Enterprise Value
- -Div Yield
- -Trading Activity
Track Vanguard S&P 500 Growth Index Fund ETF (VOOG) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Vanguard S&P 500 Growth Index Fund ETF has traded between a low of $65.32 and a high of $85.69, highlighting its annual price range. Buy and sell Vanguard S&P 500 Growth Index Fund ETF shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Vanguard S&P 500 Growth Index Fund ETF
VOOG is an index-based ETF that tracks the S&P 500 Growth Index, composed of the growth-oriented companies within the S&P 500. It selects constituents based on three key metrics—sales growth, the ratio of earnings change to price, and momentum—offering a highly liquid and low-cost way to capture the high-performing 'growth slice' of the broader U.S. large-cap market.
Most Recent News
Autoliv advances virtual crash testing with Human Body Model, Toyota first to adopt platform.
Autoliv has developed the Human Body Model (HBM) Safety Suite, a virtual testing platform that simulates detailed human anatomy responses in car crashes. This technology complements physical crash tests by providing deeper insights into injury mechan...

Beta Bionics sued for misleading investors on insulin pump safety and FDA issues, stock price fell.
Schall, Brown & Schwartz LLP filed a class action lawsuit against Beta Bionics for allegedly making false statements about the safety and regulatory status of its iLet Bionic Pancreas insulin pump. The complaint claims Beta Bionics misled investors b...

Class action lawsuit alleges Beta Bionics misled investors on FDA safety findings for its insulin pump.
Beta Bionics faces a class action lawsuit for allegedly making false statements about the safety and regulatory status of its iLet Bionic Pancreas insulin pump. The lawsuit claims the company misled investors by downplaying FDA concerns after a facil...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.